Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Business of developing and commercializing CAR T therapies10.09M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States of America1.35M79.62%
United Kingdom346K20.38%